Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

doi:10.3748/wjg.15.942

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6186)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

641

HTML

5124

Figures (1-3)

219

Tables (1-3)

202

Sum=6186

Feb 28, 2009 (publication date) through Sep 23, 2024

Times Cited of This Article

Times Cited (137)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Feb 28, 2009; 15(8): 942-954
Published online Feb 28, 2009. doi: 10.3748/wjg.15.942

Table 1 Demographics and baseline data at inclusion (mean ± SE)

	Units	Overall patients	Group		P
	Units	Overall patients	T	V
No. of patients		54	28	26	P	NS
Gender	Male/female	28/26	14/14	12/14	NS
Age	yr	48.89 ± 1.41	48 ± 1.98	49.85 ± 2.05	NS
BMI (V1)	kg/m²	27.42 ± 0.36	27.21 ± 0.51	27.65 ± 0.53	NS
dBP (V1)	mmHg	101.65 ± 1.05	101.43 ± 1.17	101.89 ± 1.8
sBP (V1)	mmHg	156.53 ± 1.28	155.71 ± 1.61	157.42 ± 2.04
ALT (V1)	IU/L	67.65 ± 2.01	66.96 ± 2.95	68.38 ± 2.75	NS
AST (V1)	IU/L	70.31 ± 2.34	72.78 ± 3.53	67.65 ± 3.02
GGT (V1)	IU/L	23.85 ± 1.62	22.60 ± 2.37	25.19 ± 2.22
B (V1)	mg/dL	0.89 ± 0.02	0.9 ± 0.03	0.88 ± 0.04
HOMA IR (V1)	units	7.7 ± 0.24	7.81 ± 0.40	7.58 ± 0.25
IRI (V1)	&mgr;U/mL	27.64 ± 0.86	27.78 ± 1.14	27.50 ± 1.32
FPG (V1)	mg/dL	113.83 ± 1.98	113.60 ± 2.77	114.07 ± 2.88
HDL-C (V1)	mg/dL	42.44 ± 1.2	42.34 ± 1.68	42.54 ± 1.77	NS¹
		M: 37.8 ± 1.38	M: 37.45 ± 1.86	M: 38.16 ± 2.11
		F: 47.42 ± 1.5	F: 47.23 ± 2.13	F: 47.66 ± 2.19
TC (V1)	mg/dL	196.46 ± 1.13	196.07 ± 1.5	196.88 ± 1.73	NS¹
		M: 200.82 ± 1.2	M: 200.57 ± 1.29	M: 201.07 ± 2.07
		F: 191.77 ± 1.5	F: 191.57 ± 2.13	F: 192 ± 2.19
TG (V1)	mg/dL	161.51 ± 4.91	165.64 ± 6.95	157.08 ± 7.18
NAS (V1)	points	5.89 ± 0.14	6 ± 0.18	5.77 ± 0.22	NS
Steatosis (V1)		2.16 ± 0.09	2.21 ± 0.12	2.11 ± 0.16
Lobular inflammation (V1)		1.70 ± 0.06	1.68 ± 0.09	1.73 ± 0.09
Ballooning (V1)		2.02 ± 0.1	2.11 ± 0.13	1.92 ± 0.16
Fibrosis (V1)	points	2.11 ± 0.11	2.07 ± 0.16	2.15 ± 0.15	NS

BMI: Body mass index; dBP: Diastolic blood pressure; sBP: Systolic blood pressure; ALT: Alanine-aminotransferase; AST: Aspartate-aminotransferase; GGT: Gamma-glutamyl transpeptidase; B: Bilirubin; HOMA-IR: Homeostasis model assessment index for insulin-resistance; IRI: Plasma immunoreactive insulin; FPG: Fasting plasma glucose; TC: Total cholesterol; HDL-C: High density lypoprotein-cholesterol; TG: Triglycerides; NAS: NASH activity score; M: Male patients; F: female patients; V1: index data at visit 1;

¹Statistics performed depending on gender and also in overall patients.

Citation: Georgescu EF, Ionescu R, Niculescu M, Mogoanta L, Vancica L. Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis. World J Gastroenterol 2009; 15(8): 942-954
URL: https://www.wjgnet.com/1007-9327/full/v15/i8/942.htm
DOI: https://dx.doi.org/10.3748/wjg.15.942